Orca Bio

Quality Commercial Site Onboarding Manager

Remote

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Life SciencesIndustries

Requirements

Candidates should possess a Bachelor’s degree in Business Administration, Project Management, Healthcare, or a related field, and a minimum of 3-5 years of experience in onboarding, project management, or quality assurance. Demonstrated experience managing complex projects is essential, along with a strong understanding of quality standards and industry regulations.

Responsibilities

The Quality Commercial Site Onboarding Manager will lead and manage the end-to-end onboarding process for commercial sites, coordinating with internal teams to ensure a seamless transition for new clients and commercial sites. This role involves conducting site assessments and audits, providing guidance and training to new partners, monitoring onboarding progress, and proactively addressing challenges or delays while maintaining clear communication with stakeholders. Furthermore, the manager will develop and maintain documentation, collaborate with the quality assurance team, and serve as the primary point of contact for clients during the onboarding phase.

Skills

Project Management
Quality Management
Customer Relationship Management
Stakeholder Communication
Process Coordination
Training and Guidance

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Key Metrics

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI